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itotal of 190 abstracts were submitted to the Pediatric
ardiology and Adult Congenital Heart Disease Sessions;
9 were accepted for presentation either as oral or poster
resentations.
Three abstracts were selected for featured poster presen-
ations in the Pediatric Cardiology/Adult Congenital Heart
isease Sessions. A study by Veldtman et al. (1) from
outhampton, United Kingdom, evaluated long-term un-
uspected hepatic injury in patients who underwent the
ontan operation. Seven patients who were evaluated for
ontan conversion late after the Fontan operation showed
triking changes of congestion, fibrosis, and cirrhosis on
iver biopsies, despite preservation of synthetic hepatic
unction on routine blood testing. Importantly, the changes
n the liver did not correlate with resting hemodynamics.
hese findings are concerning and suggest that in the older
atient with congenital heart disease, potential for func-
ional incapacity due to non-cardiac etiologies must be
onsidered. The demonstration of serologically unsuspected
epatic inflammation in older patients after the Fontan
peration recognizes the potential for increased morbidity.
t is not clear, however, whether the findings are applicable
o all patients with the Fontan circulation, because the
opulation examined in this study were patients being
onsidered for Fontan take-down.
Much interest is present in alternatives to radiographic
maging to decrease procedural risk, as well as to improve
hysiologic measurements during diagnostic evaluation or
ntervention. A second featured poster by Telep et al. (2),
rom the National Heart, Lung, and Blood Institute of the
ational Institutes of Health, evaluated real-time magnetic
esonance imaging (MRI)-guided coarctation stent repair in
n animal model. In a swine model of coarctation stenting,
he gradient was reduced and follow-up catheterization and
ecropsy showed durable results. The investigators noted
hat an active antenna guidewire shortened the procedure
ime compared with passive nitinol guidewires by improving
tent visualization. They concluded that stent delivery for
ortic coarctation, entirely using real-time MRI with com-
ercially available devices is feasible. This study is provoc-
tive and may presage the use of MRI for interventional
echniques in the near future.
A third featured poster by Heistein et al. (3), from the
niversity of Texas Southwestern Medical Center and
hildren’s Medical Center in Dallas, evaluated a cross-
ectional study of 80 children receiving aspirin for various
ndications, including both cyanotic and acyanotic children
ith congenital heart disease. The authors found thatwFrom Children’s Hospital and Brigham and Women’s Hospital, Boston, Massachusetts.lmost one-third of these patients had aspirin resistance,
hich was not due to a lack of inhibition of platelet
hromboxane production, suggesting that alternative sources
f thromboxane and thromboxane-independent mecha-
isms, such as adenosine triphosphate-induced platelet
ctivation, may contribute to aspirin resistance in this
opulation. This demonstration of potential aspirin resis-
ance highlights the importance of non-anatomic vascular
nd circulatory factors in older individuals with congenital
eart disease.
Several abstracts evaluated the use of B-type natriuretic
eptide (BNP) as a useful bedside screening marker for
arious hemodynamic effects. One study by Sanjeev et al.
4) from the Children’s Hospital of Detroit, Michigan,
uggested that plasma BNP levels are useful bedside
creening tests for abnormal cardiac function and
nthrocylcline-induced cardio-toxicity. Another study by
he same author (5) used BNP as a screening tool for
iagnosis and treatment of hemodynamically significant
atent ductus arteriosus. Patients with BNP levels over
0 pg/ml were noted to have hemodynamically significant
atent ductus arteriosus, which may improve decision
aking regarding medical and surgical therapy to close
he ductus in premature infants.
A further study by Connolly et al. (6) from New York
niversity suggested that BNP levels have diagnostic value
n children with heart failure. A BNP level of 100 pg/ml is
uggestive of heart failure, whereas a level 400 pg/ml is
uggestive of a critical threshold for risk of mortality and/or
orbidity. A fourth study by Brili et al. (7) from Athens,
reece, suggested that BNP levels correlate with right
entricular dilation in tetralogy of Fallot, suggesting a
on-invasive way of evaluating the changes in right ventric-
lar dilatation over time.
Several studies looked at nesiritide as a new agent for use
n children with congestive heart failure. Studies by Mahle
t al. (8) from Atlanta, Georgia, and Jefferies et al. (9) from
aylor College of Medicine in Houston, Texas, showed that
esiritide infusions in children with congestive heart failure
mproved natriuresis and diuresis and improved, in addition,
ppetite and functional status, adding a new drug to our
rmamentarium in children to treat congestive heart failure,
ither in anticipation of or in order to preclude cardiac
ransplantation.
Several notable abstracts were presented in the Congen-
tal Heart Disease Surgery and Interventional Cardiology
essions. Chang et al. (10) from Los Angeles, California,
ecognized female gender to be associated with 18% higher
n-hospital mortality after congenital heart defect repair. It
as not clear from the abstract whether the mortality was
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ACC 2005 Annual Session Highlights June 7, 2005:9B–11Besion-specific. The accrued mortality rates were not statis-
ically different between genders, but fewer neonatal oper-
tions and lower-risk procedures were noted in the female
opulation studied. The author’s also noted that low-
olume hospitals had higher mortality than high-volume
ospitals for both genders. A study by Fedderly et al. (11)
rom Milwaukee, Wisconsin, noted that in a series of 72
atients with hypoplastic left heart syndrome, aortic valve
tresia was associated with increased mortality only in the
resence of a patent mitral valve. This study suggests that
he hypertensive left ventricle adds a risk factor to both
n-hospital mortality, 30-day mortality, and survival to stage
I palliation.
Singh et al. (12) from Washington University in St.
ouis, Missouri, evaluated patients with single left ven-
ricle by MRI more than 10 years post-Fontan procedure
nd noted that segmental and diffuse myocardial fibrosis
nd scarring was common, suggesting that fibrosis may
ontribute to abnormal contractile mechanisms, possibly
esulting in impaired ventricular systolic function and
iastolic dysfunction, which can affect long-term out-
omes in these patients.
Another study from Davis et al. (13) from the Children’s
ospital of Philadelphia, evaluated exercise performance
fter pediatric heart transplantation. The findings of this
tudy suggested that exercise performance is impaired after
ransplant and continues to decline over time. This de-
reased performance is largely related to diastolic dysfunc-
ion rather than a decrease in systolic function.
Interventional catheterization sessions included the pre-
entation of a multicenter evaluation of the Helex atrial
eptal occluder device (W.L. Gore & Associates, Flagstaff,
rizona). The abstract by Jones et al. (14) from Seattle,
ashington, included results from 14 U.S. sites and showed
hat the Helex septal occluder compares favorably to surgical
epair, with reduced anesthesia time and reduced hospital
tay.
A study by Marshall et al. (15) from Boston, Massa-
husetts, looked at the technical aspects of fetal aortic
alve dilation. They reported technical success in 20 of 26
etuses between 21 and 31 weeks’ gestational age. The
uthors noted a balloon/annulus ratio of 1.1 to 1 resulted
n improvement of antegrade flow; however, at least
oderate aortic regurgitation occurred in 25% of cases.
he aortic regurgitation appeared to be well tolerated and
mproved over time, suggesting that the stenotic fetal
ortic valve responds in a unique fashion to balloon
alvuloplasty.
The adult congenital heart sessions included an abstract
y Diller et al. (16) from London, United Kingdom,
howing chronotropic incompetence is prevalent in patients
ith single ventricle physiology and is associated with
educed exercise capacity. These findings suggest that im-
lantation of rate-responsive pacemakers could offer func-
ional benefits to these patients.This summary includes only a portion of the highlights of
he pediatric cardiology and congenital heart disease sec-
ions of American College of Cardiology 2005 Annual
ession. The application of new technologies and the
ontinued evaluation of long-term outcomes in children
ith complex congenital heart disease as they age into
dulthood continue to provide important new information
nd areas for further investigation.
eprint requests and correspondence: Dr. Thomas L. Spray,
hildren’s Hospital of Philadelphia, Chief, Cardiothoracic Sur-
ery, 34th & Civic Center Boulevard, Suite 8527, Philadelphia,
ennsylvania 19104. E-mail: spray@email.chop.edu.
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